Previous Statements by MRK
» Merck & Co.'s CEO Discusses Q4 2011 Results - Earnings Call Transcript
» Merck & Co. Inc. - Special Call
» Merck & Co.'s CEO Discusses Q3 2011 Results - Earnings Call Transcript
The Merck collab would count as Leap's first of planned studies with immunotherapies, but the collaboration is not Keytruda's first rodeo.
Jim Cramer discusses not discussing the 'market' and also suggests a Darth Vader-Amazon meeting.